Belite Bio (BLTE) Financials: Revenue & Earnings

BLTE price $147.37 +1.65 +1.13%

Ticker
BLTE
Price
$147.37
Change
+1.65 +1.13%
Market cap ?
$5.93B
P/E ?
-51.94
Forward P/E ?
77.56
Dividend yield ?
0.00%
Beta ?
-1.23
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
46
Quality
46
Growth
100

Stocklytics score rationale: value 46, quality 46, growth 100.

Financials

202020212022202320242025
000000

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is…

Fair value

BLTE fair value $74.63. Price $147.37. Price is 97% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare BLTE

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.79——
2026-08-12-0.70-0.73——
2026-05-20-0.34-0.60——
2026-03-02-0.38-0.56—16.67M
2025-11-10-0.65-0.53——
2025-08-11-0.50-0.47——
2025-05-13-0.45-0.36——
2025-03-17-0.32-0.30——
2024-11-12-0.28-0.30——
2024-08-09-0.31-0.28——
2024-05-13-0.27-0.34——
2024-03-11-0.25-0.36——
2023-11-13-0.40-0.31——
2023-08-08-0.26-0.24——
2023-05-10-0.33-0.20——
2023-03-31-1.04-0.22——
2022-09-30-0.10———
2022-08-10-0.12-0.23——
2022-04-29-0.26———
2022-03-31-0.05———
2021-09-30-0.26———
2021-06-30-0.25———
2021-03-31-0.25———
2020-12-31-0.21———
2020-09-30-0.21———
2020-06-30-0.12———
2020-03-31-0.12———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Scholl Hendrik PeterSell200$163.6232.73K
2026-10-01Scholl Hendrik PeterSell24$164.643.95K
2026-10-01Scholl Hendrik PeterSell120$165.4919.86K
2026-10-01Scholl Hendrik PeterSell50$166.448.32K
2026-10-01Scholl Hendrik PeterSell78$167.5913.07K
2026-10-01Scholl Hendrik PeterSell12$168.212.02K
2026-10-01Scholl Hendrik PeterSell14$169.362.37K
2026-10-01Scholl Hendrik PeterSell2$170.02340
2026-09-08Lin Yu-HsinSell2.40K$194.33466.40K
2026-09-08Lin Yu-HsinSell6.09K$195.621.19M
2026-09-08Lin Yu-HsinSell6.06K$196.541.19M
2026-09-08Lin Yu-HsinSell8.75K$197.361.73M
2026-09-08Lin Yu-HsinSell2.70K$198.09534.84K
2026-09-08Chuang Hao-YuanSell2.20K$194.28427.41K
2026-09-08Chuang Hao-YuanSell4.12K$195.60805.89K
2026-09-08Chuang Hao-YuanSell4.47K$196.47879.20K
2026-09-08Chuang Hao-YuanSell4.61K$197.23908.24K
2026-09-08Chuang Hao-YuanSell2.56K$198.05507.39K
2026-09-04Lin Yu-HsinSell2.63K$180.29475.07K
2026-09-04Lin Yu-HsinSell2.59K$181.24468.88K
2026-09-04Lin Yu-HsinSell3.41K$182.50622.87K
2026-09-04Lin Yu-HsinSell4.96K$183.30908.23K
2026-09-04Lin Yu-HsinSell6.25K$184.521.15M
2026-09-04Lin Yu-HsinSell4.59K$185.34851.29K
2026-09-04Lin Yu-HsinSell7.80K$186.321.45M
2026-09-04Lin Yu-HsinSell6.20K$187.251.16M
2026-09-04Lin Yu-HsinSell3.04K$188.26573.25K
2026-09-04Lin Yu-HsinSell8.96K$189.341.70M
2026-09-04Lin Yu-HsinSell600$190.39114.23K
2026-09-04Lin Yu-HsinSell11.08K$191.152.12M
2026-09-04Lin Yu-HsinSell4.21K$192.54810.41K
2026-09-04Lin Yu-HsinSell8.11K$193.131.57M
2026-09-04Chuang Hao-YuanSell1.63K$180.16294.20K
2026-09-04Chuang Hao-YuanSell2.00K$181.05362.11K
2026-09-04Chuang Hao-YuanSell2.00K$182.49364.99K
2026-09-04Chuang Hao-YuanSell3.76K$183.27688.90K
2026-09-04Chuang Hao-YuanSell3.57K$184.57658.74K
2026-09-04Chuang Hao-YuanSell3.87K$185.28717.41K
2026-09-04Chuang Hao-YuanSell4.60K$186.34857.19K
2026-09-04Chuang Hao-YuanSell3.90K$187.16729.94K
2026-09-04Chuang Hao-YuanSell1.90K$188.59358.32K
2026-09-04Chuang Hao-YuanSell6.20K$189.221.17M
2026-09-04Chuang Hao-YuanSell1.80K$190.63343.14K
2026-09-04Chuang Hao-YuanSell6.20K$191.091.18M
2026-09-04Chuang Hao-YuanSell3.40K$192.40653.79K
2026-09-04Chuang Hao-YuanSell4.60K$193.12888.73K
2026-08-12Chuang Hao-YuanSell144$180.0025.92K
2026-08-12Chuang Hao-YuanSell223$180.5740.27K
2026-08-12Lin Yu-HsinSell142$180.0025.56K
2026-08-12Lin Yu-HsinSell223$180.5740.27K
2026-06-18Scholl Hendrik PeterSell96$143.9013.81K
2026-06-18Scholl Hendrik PeterSell3.75K$144.66542.19K
2026-06-18Scholl Hendrik PeterSell4.86K$145.43706.96K
2026-06-18Scholl Hendrik PeterSell1.20K$146.24175.35K
2026-06-18Scholl Hendrik PeterSell96$147.1114.12K
2026-06-16Scholl Hendrik PeterSell2.05K$137.61282.64K
2026-06-16Scholl Hendrik PeterSell784$138.18108.33K
2026-06-16Scholl Hendrik PeterSell3.14K$139.57438.26K
2026-06-16Scholl Hendrik PeterSell540$140.5875.91K
2026-06-16Scholl Hendrik PeterSell100$141.8314.18K
2026-06-16Scholl Hendrik PeterSell450$142.2063.99K
2026-06-16Scholl Hendrik PeterSell1.90K$143.55272.31K
2026-06-16Scholl Hendrik PeterSell1.03K$145.02150.10K
2026-05-07MATA NATHAN L.Sell226$152.4534.45K
2026-05-07MATA NATHAN L.Sell428$153.5665.73K
2026-05-07MATA NATHAN L.Sell3$154.61464
2026-05-07MATA NATHAN L.Sell9$155.251.40K
2026-05-06MATA NATHAN L.Sell8$151.571.21K
2026-05-06MATA NATHAN L.Sell424$152.6764.73K
2026-05-06MATA NATHAN L.Sell128$153.4219.64K
2026-05-06MATA NATHAN L.Sell240$154.4137.06K
2026-05-06MATA NATHAN L.Sell100$155.9715.60K
2026-05-06MATA NATHAN L.Sell100$156.0015.60K
2026-05-05MATA NATHAN L.Sell120$153.9218.47K
2026-05-05MATA NATHAN L.Sell363$154.4456.06K
2026-05-05MATA NATHAN L.Sell173$155.4826.90K
2026-05-05MATA NATHAN L.Sell121$156.5318.94K
2026-05-05MATA NATHAN L.Sell155$157.2924.38K
2026-05-05MATA NATHAN L.Sell68$158.1110.75K
2026-05-04MATA NATHAN L.Sell32$153.504.91K
2026-05-04MATA NATHAN L.Sell236$154.2436.40K
2026-05-04MATA NATHAN L.Sell325$155.2150.44K
2026-05-04MATA NATHAN L.Sell235$156.5736.79K
2026-05-04MATA NATHAN L.Sell172$157.4927.09K
2026-05-01MATA NATHAN L.Sell52$153.898.00K
2026-05-01MATA NATHAN L.Sell288$154.3844.46K
2026-05-01MATA NATHAN L.Sell346$155.4853.79K
2026-05-01MATA NATHAN L.Sell82$156.2412.81K
2026-05-01MATA NATHAN L.Sell106$157.4516.69K
2026-05-01MATA NATHAN L.Sell65$158.3510.29K
2026-05-01MATA NATHAN L.Sell38$159.086.04K
2026-05-01MATA NATHAN L.Sell23$160.003.68K
2026-04-30MATA NATHAN L.Sell42$155.686.54K
2026-04-30MATA NATHAN L.Sell517$156.5980.96K
2026-04-30MATA NATHAN L.Sell340$157.3753.51K
2026-04-30MATA NATHAN L.Sell101$158.1515.97K
2026-04-29MATA NATHAN L.Sell278$154.5842.97K
2026-04-29MATA NATHAN L.Sell259$155.5240.28K
2026-04-29MATA NATHAN L.Sell339$156.4353.03K
2026-04-29MATA NATHAN L.Sell102$157.3916.05K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 82, holders +7 vs prior quarter. Ownership 23.58%.

HolderSharesChangeChange %Value
DARWIN GLOBAL MANAGEMENT, LTD.3.08M19.81K+0.65%456.59M
PARADIGM BIOCAPITAL ADVISORS LP1.23M118.09K+10.59%189.84M
RTW INVESTMENTS, LP715.33K00.00%110.15M
MILLENNIUM MANAGEMENT LLC494.56K-75.52K-13.25%76.16M
MAVERICK CAPITAL LTD396.31K396.31KNew61.03M
EVENTIDE ASSET MANAGEMENT, LLC390.83K33.18K+9.28%60.18M
DEERFIELD MANAGEMENT COMPANY, L.P.357.20K53.19K+17.49%55.00M
HOLOCENE ADVISORS, LP251.03K-243.46K-49.23%38.66M
LOGOS GLOBAL MANAGEMENT LP250.00K250.00KNew38.50M
MORGAN STANLEY235.07K33.66K+16.71%36.20M
UBS GROUP AG224.99K-543.37K-70.72%34.64M
CITADEL ADVISORS LLC186.17K184.16K+9171.31%28.67M
GOLDMAN SACHS GROUP INC166.19K60.68K+57.51%25.59M
AFFINITY ASSET ADVISORS, LLC165.00K100.00K+153.85%25.41M
MPM BIOIMPACT LLC137.21K49.16K+55.84%21.13M
BANK OF AMERICA CORP /DE/124.78K121.00K+3202.89%19.21M
PATIENT SQUARE CAPITAL LP110.00K-6.68K-5.73%16.94M
DUQUESNE FAMILY OFFICE LLC106.10K00.00%16.34M
PRICE T ROWE ASSOCIATES INC /MD/105.86K-175.95K-62.44%16.30M
JANE STREET GROUP, LLC65.80K53.58K+438.38%10.13M
BNP PARIBAS FINANCIAL MARKETS57.12K24.60K+75.63%8.80M
RENAISSANCE TECHNOLOGIES LLC55.76K3.76K+7.24%8.59M
POINT72 ASSET MANAGEMENT, L.P.51.19K51.19KNew7.88M
SOLEUS CAPITAL MANAGEMENT, L.P.50.52K50.52KNew7.78M
TREXQUANT INVESTMENT LP49.52K34.44K+228.53%7.62M

Earnings and financials

Belite Bio, Inc (BLTE) trades at $147.37, with a market cap of $5.93B and a trailing P/E of -51.94. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

202020212022202320242025
000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Belite Bio (BLTE) Financials: Revenue & Earnings

BLTE$147.37+1.65 +1.13%

$5.93B

Market Cap

-51.94

P/E

77.56

Forward P/E

64

Score

Price History